Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process
BACKGROUND AND AIM: Vaccines providing protection against COVID-19 are a core tool for ending the pandemic. Though international organisations created guidance in 2020 for vaccine deployment, this had to be adapted for each country’s situation and values. We aimed to assist public health decision ...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2021-09-01
|
| Series: | Swiss Medical Weekly |
| Online Access: | https://www.smw.ch/index.php/smw/article/view/3084 |
| _version_ | 1827006747866300416 |
|---|---|
| author | Kevin Selby Marc-Antoine Bornet Yann Sancosme Erik von Elm Valérie d’Acremont Serge de Valliere Jacques Cornuz Blaise Genton |
| author_facet | Kevin Selby Marc-Antoine Bornet Yann Sancosme Erik von Elm Valérie d’Acremont Serge de Valliere Jacques Cornuz Blaise Genton |
| author_sort | Kevin Selby |
| collection | DOAJ |
| description |
BACKGROUND AND AIM: Vaccines providing protection against COVID-19 are a core tool for ending the pandemic. Though international organisations created guidance in 2020 for vaccine deployment, this had to be adapted for each country’s situation and values. We aimed to assist public health decision makers by identifying areas of consensus among Swiss experts for the deployment of one or more novel COVID-19 vaccines.
METHODS: An electronic, modified Delphi process between September and November 2020. We recruited a convenience sample of experts working in Switzerland from a variety of specialities, who completed two anonymous questionnaires. They voted on clarification questions and guidance statements from 0 (complete disagreement) to 10 (complete agreement). Responses for guidance statements with a median ≥8 and a lower inter-quartile range bound ≥7 were considered as reaching consensus.
RESULTS: Sixty-five experts accepted (66% response rate), with 47 completing the first questionnaire (72%), and 48 the second (74%). Statements reaching consensus included: in the first phase we should vaccinate front-line healthcare professionals and people ≥65 years with risk factors; widespread vaccination of children and adolescents should not be an early priority; and vaccines should be provided free of charge in the setting of national or cantonal vaccination campaigns. Statements not reaching consensus included: early vaccination of people living with someone with risk factors who are not themselves at risk; vaccination of people with previous confirmed or suspected COVID-19; and whether vaccination should be mandatory for individuals with certain activities, such as front-line healthcare professionals.
CONCLUSIONS: Experts reached consensus on several statements that were available for decision-makers when making key decisions for COVID-19 vaccine deployment in Switzerland. Statements without consensus highlighted areas requiring expert and public dialogue. The modified Delphi process allowed us to rapidly synthesise views from a broad panel of experts on sensitive topics, and could be considered for a broad range of issues during public health crises.
|
| first_indexed | 2024-04-11T04:27:12Z |
| format | Article |
| id | doaj.art-8b4ee23ed68c4a97bb07c0091272aa01 |
| institution | Directory Open Access Journal |
| issn | 1424-3997 |
| language | English |
| last_indexed | 2025-02-18T12:08:57Z |
| publishDate | 2021-09-01 |
| publisher | SMW supporting association (Trägerverein Swiss Medical Weekly SMW) |
| record_format | Article |
| series | Swiss Medical Weekly |
| spelling | doaj.art-8b4ee23ed68c4a97bb07c0091272aa012024-11-02T04:59:56ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972021-09-01151394010.4414/SMW.2021.w30076Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi processKevin SelbyMarc-Antoine BornetYann SancosmeErik von ElmValérie d’AcremontSerge de ValliereJacques CornuzBlaise Genton BACKGROUND AND AIM: Vaccines providing protection against COVID-19 are a core tool for ending the pandemic. Though international organisations created guidance in 2020 for vaccine deployment, this had to be adapted for each country’s situation and values. We aimed to assist public health decision makers by identifying areas of consensus among Swiss experts for the deployment of one or more novel COVID-19 vaccines. METHODS: An electronic, modified Delphi process between September and November 2020. We recruited a convenience sample of experts working in Switzerland from a variety of specialities, who completed two anonymous questionnaires. They voted on clarification questions and guidance statements from 0 (complete disagreement) to 10 (complete agreement). Responses for guidance statements with a median ≥8 and a lower inter-quartile range bound ≥7 were considered as reaching consensus. RESULTS: Sixty-five experts accepted (66% response rate), with 47 completing the first questionnaire (72%), and 48 the second (74%). Statements reaching consensus included: in the first phase we should vaccinate front-line healthcare professionals and people ≥65 years with risk factors; widespread vaccination of children and adolescents should not be an early priority; and vaccines should be provided free of charge in the setting of national or cantonal vaccination campaigns. Statements not reaching consensus included: early vaccination of people living with someone with risk factors who are not themselves at risk; vaccination of people with previous confirmed or suspected COVID-19; and whether vaccination should be mandatory for individuals with certain activities, such as front-line healthcare professionals. CONCLUSIONS: Experts reached consensus on several statements that were available for decision-makers when making key decisions for COVID-19 vaccine deployment in Switzerland. Statements without consensus highlighted areas requiring expert and public dialogue. The modified Delphi process allowed us to rapidly synthesise views from a broad panel of experts on sensitive topics, and could be considered for a broad range of issues during public health crises. https://www.smw.ch/index.php/smw/article/view/3084 |
| spellingShingle | Kevin Selby Marc-Antoine Bornet Yann Sancosme Erik von Elm Valérie d’Acremont Serge de Valliere Jacques Cornuz Blaise Genton Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process Swiss Medical Weekly |
| title | Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process |
| title_full | Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process |
| title_fullStr | Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process |
| title_full_unstemmed | Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process |
| title_short | Expert guidance for COVID-19 vaccine deployment in Switzerland: a Delphi process |
| title_sort | expert guidance for covid 19 vaccine deployment in switzerland a delphi process |
| url | https://www.smw.ch/index.php/smw/article/view/3084 |
| work_keys_str_mv | AT kevinselby expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT marcantoinebornet expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT yannsancosme expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT erikvonelm expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT valeriedacremont expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT sergedevalliere expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT jacquescornuz expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess AT blaisegenton expertguidanceforcovid19vaccinedeploymentinswitzerlandadelphiprocess |